Cargando…
Evading Doxorubicin-Induced Systemic Immunosuppression Using Ultrasound-Responsive Liposomes Combined with Focused Ultrasound
Doxorubicin (DOX) is a representative anticancer drug with a unique ability to induce immunogenic cell death of cancer cells. However, undesired toxicity on immune cells has remained a significant challenge, hindering the usage of DOX in cancer immunotherapy. Here, we report a combined therapy to av...
Autores principales: | Lee, Jeongjin, Um, Wooram, Moon, Hyungwon, Joo, Hyeyeon, Song, Yeari, Park, Minsung, Yoon, Been, Kim, Hyun-Ryoung, Park, Jae Hyung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9784431/ https://www.ncbi.nlm.nih.gov/pubmed/36559097 http://dx.doi.org/10.3390/pharmaceutics14122603 |
Ejemplares similares
-
Ultrasound-Responsive Liposomes for Targeted Drug Delivery Combined with Focused Ultrasound
por: Kim, Yoon-Seok, et al.
Publicado: (2022) -
Effects of Lipid Shape and Interactions on the Conformation, Dynamics, and Curvature of Ultrasound-Responsive Liposomes
por: Lee, Hwankyu, et al.
Publicado: (2022) -
Combination Therapy with Doxorubicin-Loaded Reduced Albumin Nanoparticles and Focused Ultrasound in Mouse Breast Cancer Xenografts
por: Kim, Daehyun, et al.
Publicado: (2020) -
Deep tissue penetration of nanoparticles using pulsed-high intensity focused ultrasound
por: You, Dong Gil, et al.
Publicado: (2017) -
Treating glioblastoma multiforme with selective high-dose liposomal doxorubicin chemotherapy induced by repeated focused ultrasound
por: Yang, Feng-Yi, et al.
Publicado: (2012)